RET kinase inhibitors

Disclosed herein are compounds of formula I:or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are...

Full description

Saved in:
Bibliographic Details
Main Authors Andrews, Steven W, McKenney, Megan L, Pancaldi, Thomas Pierre Dino, Irvin, Thomas C, McFaddin, Elizabeth A, Condroski, Kevin R, Pilkington-Miksa, Michael Alexander, Kolakowski, Gabrielle R, Anderson, Erin D, Mouret, Tiphaine, Munchhof, Michael J, Kumar, Manoj, Pinto, Marta, Boldron, Christopher Pierre Albert Jean, McLean, Johnathan Alexander
Format Patent
LanguageEnglish
Published 11.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed herein are compounds of formula I:or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are also disclosed.
AbstractList Disclosed herein are compounds of formula I:or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are also disclosed.
Author Pancaldi, Thomas Pierre Dino
Boldron, Christopher Pierre Albert Jean
Irvin, Thomas C
McKenney, Megan L
Pilkington-Miksa, Michael Alexander
Kumar, Manoj
McLean, Johnathan Alexander
Munchhof, Michael J
Anderson, Erin D
Kolakowski, Gabrielle R
Condroski, Kevin R
McFaddin, Elizabeth A
Mouret, Tiphaine
Pinto, Marta
Andrews, Steven W
Author_xml – fullname: Andrews, Steven W
– fullname: McKenney, Megan L
– fullname: Pancaldi, Thomas Pierre Dino
– fullname: Irvin, Thomas C
– fullname: McFaddin, Elizabeth A
– fullname: Condroski, Kevin R
– fullname: Pilkington-Miksa, Michael Alexander
– fullname: Kolakowski, Gabrielle R
– fullname: Anderson, Erin D
– fullname: Mouret, Tiphaine
– fullname: Munchhof, Michael J
– fullname: Kumar, Manoj
– fullname: Pinto, Marta
– fullname: Boldron, Christopher Pierre Albert Jean
– fullname: McLean, Johnathan Alexander
BookMark eNrjYmDJy89L5WQQDXINUcjOzEssTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoZmluZmJuZORsbEqAEAJqci4Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US11697647B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US11697647B23
IEDL.DBID EVB
IngestDate Fri Aug 09 05:01:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US11697647B23
Notes Application Number: US202117519878
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230711&DB=EPODOC&CC=US&NR=11697647B2
ParticipantIDs epo_espacenet_US11697647B2
PublicationCentury 2000
PublicationDate 20230711
PublicationDateYYYYMMDD 2023-07-11
PublicationDate_xml – month: 07
  year: 2023
  text: 20230711
  day: 11
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Eli Lilly and Company
RelatedCompanies_xml – name: Eli Lilly and Company
Score 3.4768665
Snippet Disclosed herein are compounds of formula I:or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title RET kinase inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230711&DB=EPODOC&locale=&CC=US&NR=11697647B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmtaL1wQqyt8XuOz0swr4oQh-0u9JbSbZZGoW12BX_vpOwtV40p5DAkAx8800mMwnAA7dKlxKyMij6y4bjc8sYlIwbHnZNTgjzSlk7PBp7w9x5XriLFrzuamHUO6Ff6nFERFSBeK-Vvd7sg1ixyq3cPjKBQ-9PaRbEenM6llnNiN04DJLpJJ5EehQF-VwfzwLT9JB4HT9Ec32AbrQv0ZC8hLIqZfObUtJTOJyitKo-gxavOnAc7X5e68DRqLnwxm6Dve05dGdJpr2JCmlHE9VaMCE_yunCfZpk0dBA-cufzSzz-X4p9gW08ZDPL0EbEI9bLmGEUgdbSW2LFLx0Cnvl-n3av4Le33J6_01ew4lUjIxHmuYNtOuPT36LRFqzO6WBb01Tdpw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebzombXxWkb8X1O3soQr-ounZja2VvI-1SrEIdruK_76V0zhfNU0jgSA5-97tc7hKAW6bkOiVkJVH0lyXNZIo0ylMmGdiVGSGpkfPa4TAygkR7XOiLFrxua2Hqd0K_6scREVEZ4r2q7fV6F8Ry69zKzV1a4ND7vR9brticjnlWM2LXtS1vOnEnjug4VjIXo5klywYSr2baaK730MU2ORq8Z5tXpax_U4p_BPtTlFZWx9BiZRc6zvbntS4chM2FN3Yb7G1OoDfzYuGtKJF2hKJ8KdKCf5TTgxvfi51AQvnLn80sk_luKeoptPGQz85AGBGDKTpJCaUatpyqCslYrmXqSjeHdNiHwd9yBv9NXkMniMPxcvwQPZ3DIVcSj03K8gW0q49PdomkWqVXtTa-AQedeY8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=RET+kinase+inhibitors&rft.inventor=Andrews%2C+Steven+W&rft.inventor=McKenney%2C+Megan+L&rft.inventor=Pancaldi%2C+Thomas+Pierre+Dino&rft.inventor=Irvin%2C+Thomas+C&rft.inventor=McFaddin%2C+Elizabeth+A&rft.inventor=Condroski%2C+Kevin+R&rft.inventor=Pilkington-Miksa%2C+Michael+Alexander&rft.inventor=Kolakowski%2C+Gabrielle+R&rft.inventor=Anderson%2C+Erin+D&rft.inventor=Mouret%2C+Tiphaine&rft.inventor=Munchhof%2C+Michael+J&rft.inventor=Kumar%2C+Manoj&rft.inventor=Pinto%2C+Marta&rft.inventor=Boldron%2C+Christopher+Pierre+Albert+Jean&rft.inventor=McLean%2C+Johnathan+Alexander&rft.date=2023-07-11&rft.externalDBID=B2&rft.externalDocID=US11697647B2